Discontinued — last reported Q3 '24
Stryker Orthopaedics and Spine — Segment operating income decreased by 4.9% to $643.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 28.9%, from $499.00M to $643.00M. Over 2 years (FY 2021 to FY 2023), Orthopaedics and Spine — Segment operating income shows an upward trend with a 4.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved pricing power, better manufacturing efficiencies, or higher sales volume in the orthopaedic and spine markets, while a decrease may indicate pricing pressure, rising raw material costs, or increased investment in product innovation.
This metric represents the operating profit generated specifically by the Orthopaedics and Spine business segment, calcu...
Comparable to segment-level operating income reported by major medical device competitors in the orthopaedic and spine space, often evaluated alongside segment operating margins to normalize for size differences.
syk_segment_orthopaedics_and_spine_segment_operating_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $563.00M | $500.00M | $662.00M | $522.00M | $607.00M | $519.00M | $648.00M | $601.00M | $601.00M | $499.00M | $698.00M | $605.00M | $676.00M | $643.00M |
| QoQ Change | — | -11.2% | +32.4% | -21.1% | +16.3% | -14.5% | +24.9% | -7.3% | +0.0% | -17.0% | +39.9% | -13.3% | +11.7% | -4.9% |
| YoY Change | — | — | — | — | +7.8% | +3.8% | -2.1% | +15.1% | -1.0% | -3.9% | +7.7% | +0.7% | +12.5% | +28.9% |